Ning-Rong Gung

Ms. Ning-Rong Gung

Assistant of the department of mathematical cybernetics and informational systems
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2012 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
KCK‐W Chang
K‐W Chang
TCT‐H Chu
T‐H Chu
NGNing-Rong Gung
Ning-Rong Gung
WCW‐F Chiang
W‐F Chiang
CYC‐C Yang
C‐C Yang
SLShu-Chun Lin
Shu-Chun Lin

24 September 2013 in Arthritis & Rheumatism
Verified
Journal Article
Closed access
PDF file
Yi-Ming ChenYi-Ming Chen
Yi-Ming Chen
HCHuai‐Chia Chuang
Huai‐Chia Chuang
WLWen‐Chun Lin
Wen‐Chun Lin
CTChing‐Yi Tsai
Ching‐Yi Tsai
CWChia‐Wei Wu
Chia‐Wei Wu
Der-Yuan ChenDer-Yuan Chen
Der-Yuan Chen

12 December 2017 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
DCDer‑Yuan Chen
Der‑Yuan Chen
Yi-Ming ChenYi-Ming Chen
Yi-Ming Chen
HCHsin‑Hua Chen
Hsin‑Hua Chen
CHChia‑Wei Hsieh
Chia‑Wei Hsieh
NGNing-Rong Gung
Ning-Rong Gung
THTSAI-CHING HSU
TSAI-CHING HSU
Dysregulation of inflammasomes serves a pathogenic role in autoinflammatory diseases (AIDs) and adult-onset Still's disease (AOSD) has been categorized as an AID. The present study investigated the expression of NLR family pyrin domain containing proteins (NLRPs) inflammasome in patients with AOSD, the effect of inflammasome inhibitors on NLRP3 signaling and whether human parvovirus B19‑associated antigens can activate NLRP3 in patients with AOSD. mRNA expression levels of NLRPs in peripheral blood mononuclear cells (PBMCs) from 34 patients with AOSD and 14 healthy individuals were determined using reverse transcription‑quantitative polymerase chain reaction. Protein expression of NLRP3 was evaluated by western blotting. Supernatant cytokine levels were measured by ELISA. Among the NLRPs investigated in the present study, NLRP3 transcripts were markedly elevated and expression of NLRP2, NLRP7 and NLRP12 was decreased in patients with AOSD compared with the controls. Treatment with NLRP3 inhibitors significantly reduced downstream NLRP3 signaling in PBMCs form patients with AOSD. B19‑nonstructural protein (NS)1 stimulation of PBMCs from patients with AOSD induced significant upregulation of transcript levels of NLRP3, caspase‑1 and interleukin (IL)‑1β compared with PBMCs from healthy controls. B19‑NS1 stimulation of PBMCs from patients with AOSD induced significant increase in supernatant levels of IL‑1β and protein expression of NLRP3, caspase‑1, IL‑1β, and IL‑18 compared with healthy controls. Elevated expression of NLRP3 and its downstream inflammasome signaling components in patients with AOSD indicated a potential pathogenic role of B19‑NS1. Thus, B19‑NS1 may induce expression of IL‑1β and IL‑18 through activation of caspase‑1‑associated NLRP3‑inflammasome in AOSD.

1 January 2020 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
Yi-Ming ChenYi-Ming Chen
Yi-Ming Chen
WHWei-Ting Hung
Wei-Ting Hung
WCWan-Chun Chang
Wan-Chun Chang
CHChia-Wei Hsieh
Chia-Wei Hsieh
WCWen-Hung Chung
Wen-Hung Chung
Shuen-Iu HungShuen-Iu Hung
Shuen-Iu Hung
Adult‐onset Still’s disease (AOSD) is a rare and inflammatory disorder characterized by spiking fever, rash, arthritis, and multisystemic involvement. HLA has been shown to be associated with AOSD; however, it could not explain the innate immunity and autoinflammatory characteristics of AOSD. To assess the genetic susceptibility of AOSD, we conducted a genome‐wide association study (GWAS) on a cohort of 70 AOSD cases and 688 controls following a replication study of 36 cases and 200 controls and meta‐analysis. The plasma concentrations of associated gene product were determined. The GWAS, replication, and combined sample analysis confirmed that SNP rs11102024 on 5 ′ ‐upstream of CSF1 encoding macrophage colony‐stimulating factor (M‐CSF) was associated with AOSD ( P = 1.20 × 10 -8 , OR (95% CI): 3.28 (2.25~4.79)). Plasma levels of M‐CSF increased in AOSD patients ( n = 82, median: 9.31 pg/mL), particularly in the cases with activity score ≥ 6 ( n = 42, 10.94 pg/mL), compared to the healthy donors ( n = 68, 5.31 pg/mL) ( P < 0.0001). Patients carrying rs11102024TT genotype had higher M‐CSF levels (median: 20.28 pg/mL) than those with AA genotype (6.82 pg/mL) ( P < 0.0001) or AT genotype (11.61 pg/mL) ( P = 0.027). Patients with systemic pattern outcome were associated with elevated M‐CSF and frequently observed in TT carriers. Our data suggest that genetic variants near CSF1 are associated with AOSD and the rs11102024 T allele links to higher M‐CSF levels and systemic outcome. These results provide a promising initiative for the early intervention and therapeutic target of AOSD. Further investigation is needed to have better understandings and the clinical implementation of genetic variants nearby CSF1 in AOSD.

23 April 2021 in Life
Verified
Journal Article
Open access
PDF file
WHWei-Ting Hung
Wei-Ting Hung
Yi-Ming ChenYi-Ming Chen
Yi-Ming Chen
Shuen-Iu HungShuen-Iu Hung
Shuen-Iu Hung
HCHsin-Hua Chen
Hsin-Hua Chen
NGNing-Rong Gung
Ning-Rong Gung
Der-Yuan ChenDer-Yuan Chen
Der-Yuan Chen
Adult-onset Still’s disease (AOSD), an autoinflammatory disorder, is related to the dysregulation of NLR3-containing a pyrin domain (NLRP3)-inflammasome signaling. We aimed to investigate the associations of genetic polymorphisms of NLRP3-inflammasome signaling with AOSD susceptibility and outcome and to examine their functional property. Fifty-three candidate single-nucleotide polymorphisms (SNPs) involved in NLRP3-inflammasome response were genotyped using Sequenom MassArray on the samples from 66 AOSD patients and 128 healthy controls. The significant SNPs were validated by direct sequencing using a TaqMan SNP analyzer. Serum levels of associated gene products were examined by ELISA. One SNP rs11672725 of CARD8 gene was identified to be significantly associated with AOSD susceptibility by using MassArray and subsequent replication validation (p = 3.57 × 10−7; odds ratio 3.02). Functional assays showed that serum CARD8 levels were significantly lower in AOSD patients (median, 10,524.6 pg/mL) compared to controls (13,964.1 pg/mL, p = 0.005), while levels of caspase-1, IL-1β and IL-18 were significantly higher in patients (107.1 pg/mL, 2.1 pg/mL, and 1495.8 pg/mL, respectively) than those in controls (99.0 pg/mL, 1.0 pg/mL, and 141.4 pg/mL, respectively). Patients carrying rs11672725CC genotype had significantly higher serum caspase-1 and IL-18 levels (121.3 pg/mL and 1748.6 pg/mL) compared to those with CT/TT genotypes (72.6 pg/mL, p = 0.019 and 609.3 pg/mL, p = 0.046). A higher proportion of patients with rs11672725CC genotype had a systemic pattern of disease outcome, which was linked to low CARD8 levels. A novel variant, rs11672725, of the CARD8 gene was identified as a potential genetic risk for AOSD. Patients carrying the rs11672725CC genotype and C allele had low CARD8 levels, and were predisposed to a systemic pattern with an elevated expression of inflammasome signaling.

31 July 2009 in Oral Oncology
Verified
Journal Article
Closed access
CWCheng-Hsien Wu
Cheng-Hsien Wu
HTHsi-Feng Tu
Hsi-Feng Tu
NGNing-Rong Gung
Ning-Rong Gung
YCYa-Wei Chen
Ya-Wei Chen
CLChung-Ji Liu
Chung-Ji Liu
SKShou-Yen Kao
Shou-Yen Kao